Literature DB >> 19897705

NADPH oxidases and atherosclerosis: unraveling the details.

Nageswara R Madamanchi, Marschall S Runge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19897705      PMCID： PMC3774417          DOI： 10.1152/ajpheart.01020.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN： 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  12 in total

1.  Decreased blood pressure in NOX1-deficient mice.

Authors:  Gaetan Gavazzi; Botond Banfi; Christine Deffert; Laurence Fiette; Michela Schappi; Francois Herrmann; Karl-Heinz Krause
Journal:  FEBS Lett       Date:  2005-12-22       Impact factor: 4.124

2.  p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice.

Authors:  P A Barry-Lane; C Patterson; M van der Merwe; Z Hu; S M Holland; E T Yeh; M S Runge
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

3.  Cell transformation by the superoxide-generating oxidase Mox1.

Authors:  Y A Suh; R S Arnold; B Lassegue; J Shi; X Xu; D Sorescu; A B Chung; K K Griendling; J D Lambeth
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

4.  Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.

Authors:  Aleksandr E Vendrov; Zeenat S Hakim; Nageswara R Madamanchi; Mauricio Rojas; Chaitanya Madamanchi; Marschall S Runge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09-06       Impact factor: 8.311

5.  Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice.

Authors:  Courtney P Judkins; Henry Diep; Brad R S Broughton; Anja E Mast; Elizabeth U Hooker; Alyson A Miller; Stavros Selemidis; Gregory J Dusting; Christopher G Sobey; Grant R Drummond
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-16       Impact factor: 4.733

6.  Nox4 acts as a switch between differentiation and proliferation in preadipocytes.

Authors:  Katrin Schröder; Katalin Wandzioch; Ina Helmcke; Ralf P Brandes
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-04       Impact factor: 8.311

7.  Mitochondrial integrity and function in atherogenesis.

Authors:  Scott W Ballinger; Cam Patterson; Cynthia A Knight-Lozano; David L Burow; Caryl A Conklin; Zhaoyong Hu; Johannes Reuf; Chris Horaist; Russell Lebovitz; Glenn C Hunter; Ken McIntyre; Marschall S Runge
Journal:  Circulation       Date:  2002-07-30       Impact factor: 29.690

8.  Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells.

Authors:  Alicia N Lyle; Nita N Deshpande; Yoshihiro Taniyama; Bonnie Seidel-Rogol; Lily Pounkova; Pingfeng Du; Christopher Papaharalambus; Bernard Lassègue; Kathy K Griendling
Journal:  Circ Res       Date:  2009-07-02       Impact factor: 17.367

9.  Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation.

Authors:  Moo Yeol Lee; Alejandra San Martin; Puja K Mehta; Anna E Dikalova; Abel Martin Garrido; S Raju Datla; Erin Lyons; Karl-Heinz Krause; Botond Banfi; J David Lambeth; Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-15       Impact factor: 8.311

Review 10.  Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets.

Authors:  Vincent Jaquet; Leonardo Scapozza; Robert A Clark; Karl-Heinz Krause; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401
View more
  10 in total

Review 1.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

Review 2.  P21-activated kinase in inflammatory and cardiovascular disease.

Authors:  Domenico M Taglieri; Masuko Ushio-Fukai; Michelle M Monasky
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

Review 3.  Herbal Approach for Management of Atherosclerosis: a Review.

Authors:  Sanjiv Singh
Journal:  Curr Atheroscler Rep       Date:  2019-02-28       Impact factor: 5.113

4.  Leukocyte chemoattractant receptor FPR2 may accelerate atherogenesis.

Authors:  Wuzhou Wan; Ji-Liang Gao
Journal:  Med Hypotheses       Date:  2012-04-26       Impact factor: 1.538

Review 5.  Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.

Authors:  Rong Ma; Sarika Chaudhari; Weizu Li
Journal:  Antioxid Redox Signal       Date:  2016-03-18       Impact factor: 8.401

6.  Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways.

Authors:  Zhe Meng; Chao Yan; Qian Deng; Deng-feng Gao; Xiao-lin Niu
Journal:  Acta Pharmacol Sin       Date:  2013-05-06       Impact factor: 6.150

Review 7.  The role of oxidative stress and autophagy in atherosclerosis.

Authors:  Ida Perrotta; Saveria Aquila
Journal:  Oxid Med Cell Longev       Date:  2015-03-18       Impact factor: 6.543

8.  The Protein Disulfide Isomerase of Botrytis cinerea: An ER Protein Involved in Protein Folding and Redox Homeostasis Influences NADPH Oxidase Signaling Processes.

Authors:  Robert Marschall; Paul Tudzynski
Journal:  Front Microbiol       Date:  2017-05-29       Impact factor: 5.640

9.  An efficient proteome-wide strategy for discovery and characterization of cellular nucleotide-protein interactions.

Authors:  Yan Ting Lim; Nayana Prabhu; Lingyun Dai; Ka Diam Go; Dan Chen; Lekshmy Sreekumar; Louise Egeblad; Staffan Eriksson; Liyan Chen; Saranya Veerappan; Hsiang Ling Teo; Chris Soon Heng Tan; Johan Lengqvist; Andreas Larsson; Radoslaw M Sobota; Pär Nordlund
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

10.  From form to function: the role of Nox4 in the cardiovascular system.

Authors:  Feng Chen; Stephen Haigh; Scott Barman; David J R Fulton
Journal:  Front Physiol       Date:  2012-11-01       Impact factor: 4.566
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.